Ad is loading...
RERAX
Price
$53.01
Change
-$0.52 (-0.97%)
Updated
Nov 15 closing price
RIVKX
Price
$16.77
Change
-$0.15 (-0.89%)
Updated
Nov 15 closing price
Ad is loading...

RERAX vs RIVKX

Header iconRERAX vs RIVKX Comparison
Open Charts RERAX vs RIVKXBanner chart's image
American Funds Europacific Growth R1
Price$53.01
Change-$0.52 (-0.97%)
VolumeN/A
CapitalizationN/A
American Funds International Vntg R-4
Price$16.77
Change-$0.15 (-0.89%)
VolumeN/A
CapitalizationN/A
RERAX vs RIVKX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RERAX vs. RIVKX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RERAX is a Buy and RIVKX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RERAX has more cash in the bank: 129B vs. RIVKX (2B). RIVKX pays higher dividends than RERAX: RIVKX (1.15) vs RERAX (0.91). RERAX was incepted earlier than RIVKX: RERAX (22 years) vs RIVKX (5 years). RERAX is a more actively managed with annual turnover of: 34.00 vs. RIVKX (15.00). RERAX (250) and RIVKX (250) have matching initial minimum investment requirements. RIVKX annual gain was more profitable for investors over the last year : 9.13 vs. RERAX (7.63). RIVKX return over 5 years is better than : 18.23 vs. RERAX (3.85).
RERAXRIVKXRERAX / RIVKX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence22 years5 years-
Gain YTD3.0522.194139%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets129B2B6,447%
Annual Yield % from dividends0.911.1580%
Returns for 1 year7.639.1384%
Returns for 3 years-19.45-4.89397%
Returns for 5 years3.8518.2321%
Returns for 10 years15.89N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
APP291.096.60
+2.32%
Applovin Corp
BBDC9.950.06
+0.61%
Barings BDC
SIF3.60N/A
N/A
SIFCO Industries
CNS100.47-0.25
-0.25%
Cohen & Steers
FATE2.02-0.06
-2.88%
Fate Therapeutics